Arovella Therapeutics Limited (AU:ALA) has released an update.
Arovella Therapeutics Limited has affirmed its commitment to high ethical standards, integrity, and adherence to statutory compliance, as detailed in its latest Corporate Governance Statement for the financial year ending 30 June 2024. The comprehensive statement outlines the company’s governance framework, management responsibilities, and adherence to the ASX Corporate Governance Council’s recommendations, highlighting its dedication to transparency and shareholder engagement. Despite a small workforce, Arovella has achieved a balanced gender distribution across its staff, including at the director and senior management levels.
For further insights into AU:ALA stock, check out TipRanks’ Stock Analysis page.
